NEW ACM now offers an in-house solution for the PCR-based diagnosis of Bordetella pertussis. In addition, the assay also detects B. holmesii and B. parapertussis/bronchiseptica, which are other species of Bordetella that may cause overlapping clinical symptoms to B. pertussis. The assay is performed on the Nanosphere Verigene, an FDA-cleared multiplex PCR platform. The recommended sample is a nasopharyngeal (NP) swab collected in Universal Transport Media (UTM). Testing is performed daily and the results are reported as Detected/Not Detected for each of the Bordetella groups tested.